Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial - Infectious Diseases of Poverty - Infectious Diseas
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (COVID-19) have a substantial burden on health-care systems around the world. This is a randomized parallel controlled trial for asses…
Read More
Other Stories in Health
- Phase one trial explores novel immunotherapy for breast cancer
- New gene therapy shows promise in preventing premature births
- 5 benefits of eating soaked Kaju everyday
- Olive oil vs mustard oil: Which is healthier for the heart?
- Can beef fit in a heart-healthy diet? Review provides new insights
- Vitamin B12 deficiency: Why do some people have Vitamin B12 deficiency and what is the best way to cure it
- Why Princess Diana never wore heels while she was married to Charles
- Review: The Only One Left
- Review: Behind Closed Doors
.png)
